Clinical Trials Browser

INDUSTRY × Prostate Cancer Metastatic × cabazitaxel × Clear all

NCT02485691 2022-05-27

CARD

Phase 4 Completed

255 enrolled 21 charts

Prostate Cancer Metastatic

NCT02379390 2019-06-21

PRIMCAB

Phase 2 Terminated

8 enrolled 8 charts

Prostate Cancer Metastatic

NCT01718353 2017-11-20

TAXYNERGY

Phase 2 Completed

63 enrolled 13 charts

Prostate Cancer Metastatic

NCT01254279 2015-01-21

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Phase 3 Completed

Prostate Cancer Metastatic